Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanism of Hypoxia-Mediated Smooth Muscle Cell Proliferation Leading to Vascular Remodeling. | Biomed Res Int | 2022 | 36593773 | PubTator, text mining | PubMed |
| Effectiveness and Safety of Ozone Therapy for Dermatological Disorders: A Literature Review of Clinical Trials. | Indian J Dermatol | 2022 | 36578725 | PubTator, text mining | PubMed |
| DYRK2 downregulation in colorectal cancer leads to epithelial-mesenchymal transition induction and chemoresistance. | Sci Rep | 2022 | 36577753 | PubTator, text mining | PubMed |
| Genomic adaptation of Ethiopian indigenous cattle to high altitude. | Front Genet | 2022 | 36568400 | PubTator, text mining | PubMed |
| The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations. | Medicina (Kaunas) | 2022 | 36556919 | PubTator, text mining | PubMed |
| The Effect of Losartan on Neuroinflammation as Well as on Endothelin-1- and Serotonin-Induced Vasoconstriction in a Double-Haemorrhage Rat Model. | J Clin Med | 2022 | 36555984 | PubTator, text mining | PubMed |
| The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential. | Int J Mol Sci | 2022 | 36555792 | PubTator, text mining | PubMed |
| Chronic Active T-Cell Mediated Kidney Rejection as a Clinically Significant Type of Allograft Loss? | Diagnostics (Basel) | 2022 | 36553226 | PubTator, text mining | PubMed |
| Hyperuricemia and Endothelial Function: Is It a Simple Association or Do Gender Differences Play a Role in This Binomial? | Biomedicines | 2022 | 36551823 | PubTator, text mining | PubMed |
| Robust generation of human-chambered cardiac organoids from pluripotent stem cells for improved modelling of cardiovascular diseases. | Stem Cell Res Ther | 2022 | 36544188 | PubTator, text mining | PubMed |
| Anti-glutathione S-transferase theta 1 antibodies correlate with graft loss in non-sensitized pediatric kidney recipients. | Front Med (Lausanne) | 2022 | 36530923 | PubTator, text mining | PubMed |
An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. | Front Microbiol | 2022 | 36519165 | PubTator, text mining | PubMed |
| Acetylsalicylic Acid-Primus Inter Pares in Pharmacology. | Molecules | 2022 | 36500502 | PubTator, text mining | PubMed |
| A Review of Genetic Polymorphisms and Susceptibilities to Complications after Aneurysmal Subarachnoid Hemorrhage. | Int J Mol Sci | 2022 | 36499752 | PubTator, text mining | PubMed |
| Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival. | Int J Mol Sci | 2022 | 36499305 | PubTator, text mining | PubMed |
| Plants as Modulators of Melanogenesis: Role of Extracts, Pure Compounds and Patented Compositions in Therapy of Pigmentation Disorders. | Int J Mol Sci | 2022 | 36499134 | PubTator, text mining | PubMed |
| The Role of Bone Morphogenetic Protein Receptor Type 2 (BMPR2) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling. | Cells | 2022 | 36497082 | PubTator, text mining | PubMed |
| Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series. | Transpl Int | 2022 | 36484064 | PubTator, text mining | PubMed |
| An in silico method to assess antibody fragment polyreactivity. | Nat Commun | 2022 | 36477674 | PubTator, text mining | PubMed |
| A comparative mRNA- and miRNA transcriptomics reveals novel molecular signatures associated with metastatic prostate cancers. | Front Genet | 2022 | 36468011 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=28